Skip to content

Pathyadi Churna in the management of Garbhini chhardi.

Randomized controlled clinical study to evaluate the efficacy of pathyadi churna in management of garbhini chhardi w.s.r to Emesis gravidarum. - NIL

Status
Active, not recruiting
Phases
Phase 3
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2023/09/057168
Enrollment
80
Registered
2023-09-01
Start date
Unknown
Completion date
Unknown
Last updated
2023-09-18

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: O219- Vomiting of pregnancy, unspecified

Interventions

None listed

Sponsors

Aditya Sandeep Sonawane
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: 1.All patients diagnosed with 6th to 14th weeks of single live pregnancy with Chhard (primi and multi gravida) irrespective of parity & religion. 2.Married female patient between age of 18 – 35 years.

Exclusion criteria

Exclusion criteria: 1.Patients with second and third trimester. 2.Garbhini with Hyperemesis Gravidarum. 3.Pregnant women with vomiting due to other systemic Diseases Such as intestinal obstruction, appendicitis,Cholecystitis, hypertension, jaundice etc. 4.Known case of diabetes mellitus. 5.Multiple pregnancy.

Design outcomes

Primary

MeasureTime frame
1.Hrullhas (Nausea) 2.Chhardivega (Frequency of vomiting) 3.Aruchi (Anorexia) 4.Daurbalya (Weakness) Timepoint: Baseline- 10th, 20th & 30th Day

Secondary

MeasureTime frame
1.Hrullhas (Nausea) 2.Chhardivega (Frequency of vomiting) 3.Aruchi (Anorexia) 4.Daurbalya (Weakness) Timepoint: Baseline- 10th, 20th & 30th Day

Countries

India

Contacts

Public ContactAditya Sandeep Sonawane

Chhatrapati shahu maharaj shikshan sanstha Ayurved Mahavidyalay

dryennawar11@gmail.com9850562524

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026